Search HomeNews & EventsPress Releases PRESS RELEASES 22 November 2021 Enamine makes HFIPS reagent more accessible 09 September 2021 OpenEye Scientific Partners with Enamine to Accelerate Early Drug Discovery SANTA FE, N.M., USA, & KYIV, Ukraine – September 9, 2021 – OpenEye Scientific and Enamine, a leading global provider of billions of new screening compounds to the drug discovery market, are partnering to enable faster and more accurate virtua... 10 June 2021 Enamine implements CDD Vault to digitalize its integrated medicinal chemistry, ADME-PK and screening services The company's expansion in the biological assay space aided by the data platform SAN FRANCISCO and KYIV, Ukraine, June 10, 2021 - Enamine, a leading provider of R&D Services as well as Screening Compounds, Fragments, Building Blocks an... 24 September 2020 Enamine is selected for Horizon 2020 global project “AIDD” - Advanced Machine Learning for Innovative Drug Discovery" to boost Artificial Intelligence (AI) for chemistry and drug discovery Enamine Ltd., a leading chemical research organization and producer of the world’s largest collections of novel building blocks (225,000+) and screening compound libraries (2,740,000+), has joined the Advanced Machine Learning for Innovative Drug... 15 April 2020 Enamine and Chemspace collaborate with Blue Dolphin Lead Discovery to expand Drug Discovery Services Today Enamine, a leading provider of small molecules and drug discovery services, Chemspace, an online catalog with the largest offer of small molecules to search and buy, and Blue Dolphin Lead Discovery, a research organization focused on a fee-... 19 November 2019 Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop Optibrium™, BioSolveIT™ and Enamine™ today announce a three-way collaboration enabling efficient search of Enamine’s REAL Space directly from within Optibrium’s StarDrop™ software. This extension to StarDrop is powered by BioSolveIT’s proprietar... 24 June 2019 Atomwise and Enamine to Advance Pediatric Oncology With the World’s First and Largest Ten Billion Compound Virtual Screen Atomwise, Enamine, and top university researchers collaborate to discovery novel small molecules for the treatment of pediatric cancers using the power of AI and novel chemistry. 04 September 2018 Optibrium and Enamine collaboration extends commercial compound database access for StarDrop users Optibrium™ today announced a collaboration with Enamine. The collaboration provides StarDrop™ users with easy access to EnamineStore, a database of their commercially available screening compounds and chemical building blocks. StarDrop has been d... 04 June 2018 New REAL Space Navigator Breaks Billion Compound Barrier Enamine Ltd., a leading compound supplier and BioSolveIT GmbH, a premium provider of drug discovery software, today announced the availability of the next generation of REAL Space Navigator, an efficient search tool within the world’s largest pur... 08 February 2018 Enamine and BioSolveIT Launch the World's Largest Searchable Chemical Space for Novel Compound Sourcing Enamine and BioSolveIT today announced the launch of the ‘REAL Space Navigator’. Jointly developed, the new software tool capitalizes on Enamine’s REAL (readily accessible) virtual compound concept and provides efficient ‘search & find’ acces... 10 January 2018 Enamine supplies DSI poised fragment and analogue libraries to Diamond Light Source XChem facility and SGC Oxford screening efforts Diamond Light Source (Diamond) and the Structural Genomic Consortium (SGC) Oxford announced today that Enamine will become a key supplier of poised fragment and analogue libraries to its XChem facility. Enamine will offer a new generation of the ... 25 April 2017 Enamine to Collaborate with EMBL for Cancer Drug Discovery Research Enamine Ltd. and the European Molecular Biology Laboratory (EMBL) have agreed to establish a collaboration whereby Enamine provides library synthesis, medicinal chemistry and biological services for the discovery and development of novel small mo... 22 November 2016 Enamine and Pcovery extend drug discovery collaboration Enamine Ltd. and Danish biotech company Pcovery have announced that they have extended their collaboration for the discovery of new drugs for the treatment of invasive fungal infections and platform technology development. 01 March 2016 Chem-Space Launches to Provide Largest Global Chemical Database and Search Tool Enamine, ChemBridge Corporation, UORSY and FCH Group today announced launch of Chem-Space, a global e-procurement marketplace solution for searching, purchasing and selling chemical buildi... 18 December 2014 Enamine Announces Extension of Collaboration with Sanofi in Early Drug Discovery Following the success since 2012 the collaboration with Sanofi aiming at finding of new valuable hit series in most challenging screening campaigns has been extended. 23 September 2013 Axxam acquires a 240 000 carefully selected compounds library from Enamine for drug discovery programs Axxam S.p.A., a contract research and discovery company, announced today that an entirely new generation screening collection is now available for drug discovery programs: AXXDIV2.0 ma... 15 October 2012 ChanTest announces drug discovery services using the Enamine 3D compound library 3D Diversity Set from Enamine, containg 50 000 drug-like compounds, has been selected by ChanTest for their dicovery services using powerful HTS of Ion Channels, GPCRs and Transporters in par... 18 April 2012 Collaboration agreement has been signed with UORSY Enamine and UkrOrgSynthesis Ltd (UORSY), a leading Ukrainian supplier of chemical building blocks and compounds for high-throughput screening, announced they have signed a collaboration agreemen... 24 January 2011 Molplex and Enamine announced a new partnership Molplex and Enamine announced a new partnership to offer Enamine's screening compounds through the Molplex on-line drug design and assay ready chemical supply services. The agreement is a major... 18 October 2021 Enamine brings Levin “nitrogen-deleting” reagent to the market 24 June 2021 Enamine selects Chemspace to advance its catalog business Kyiv, Ukraine, June 24, 2021. Enamine Ltd. a provider of drug discovery services empowered with the world’s largest collections of building blocks, fragments, and screening compounds announced today that it forms a strategic alliance with Chemspa... 24 February 2021 Enamine extend collaboration with prominent Swiss Biotech A new multi-year drug discovery agreement will focus on CNS drug discovery Kyiv, Ukraine, February 24 2021 - Enamine Ltd. a provider of drug discovery services empowered with the world’s largest collections of building blo... 17 September 2020 Enamine Ltd. Released Coronavirus Library to Support COVID-19 Research Programs Enamine Ltd., a leading chemical research organization and producer of the world’s largest collections of novel building blocks (225,000+) and screening compound libraries (2,740,000+), today announced the release of the Coronavirus Library. The ... 11 March 2020 Enamine to be the exclusive supplier of Astex’ MiniFrag Library Enamine Ltd. and Astex Pharmaceuticals (UK) have cooperated to provide wide access to Astex’ MiniFrag library, an efficient Fragment-based Drug Discovery tool for identification of hot and warm spots of protein targets. The Library is readily ava... 05 November 2019 Cyclica Collaborates With Enamine to Use REAL Technology in Its Ligand Design Platform for AI-augmented Drug Design Cyclica, Inc. announced a collaboration with Enamine Ltd. to explore its huge readily accessible chemical space using Cyclica’s state-of-the-art AI-driven Ligand Design™ platform. The companies aim to empower Cyclica’s patented, evolutionary algo... 26 March 2019 Enamine extends multi-year drug discovery collaboration with Lundbeck Enamine and H. Lundbeck A/S (Lundbeck) announced the expansion of their research collaboration. Enamine will support Lundbeck’s in-house discovery chemistry competencies with three principal assets enabling Lundbeck to optimally identify and deve... 19 June 2018 Enamine and TBD Biodiscovery collaborate to provide GMP-based services Enamine and TBD Biodiscovery have entered into a collaboration agreement. The partnership aims to manage the transition of chemical synthesis of novel intermediates from laboratory to bulk scale under GMP standards utilizing Enamine’s know-how an... 15 March 2018 Enamine collaborates with ChemAxon to create a convenient web-based search in immense chemical space Enamine and ChemAxon today announced the launch of jointly-created online resource (available at EnamineStore.com) to allow researchers worldwide to explore the chemical space of REAL database. The resource is aimed to provide the drug discovery ... 25 January 2018 Enamine expands collaboration with UCSF Enamine Ltd. has today announced that it has expanded its collaboration on ZINC, a comprehensive online database of purchasable compounds curated by the Irwin and Shoichet laboratories in the Department of Pharmaceutical Chemistry at the Universi... 01 August 2017 Axxam enters into a Research Collaboration with Enamine Axxam S.p.A. and Enamine Ltd. announced the start of a Research Collaboration to enhance the Axxam small molecule screening library with the addition of a further set of compounds aimed at early-stage CNS drug discovery, achieving a total library... 23 January 2017 Enamine expands collaboration with Actelion Pharmaceuticals Enamine Ltd. has announced that it has agreed to expand its collaboration in early drug discovery with Actelion Pharmaceuticals, covering therapeutic areas including cardiovascular and central nervous system disorders, immunology, infectious dise... 24 October 2016 Enamine and FCH Group collaborate to extend compound library synthesis program Enamine Ltd., a chemical company, producer of building blocks and screening libraries, announced today that it had signed a collaboration agreement with small molecule design house FCH Group Ltd (FCH). 18 November 2015 Enamine is expanding its purification and analytical units to enhance library synthesis offering Enamine is announcing today the expansion of its Purification and Analytical Units to enable synthesis of 30 000 high quality screening library compounds monthly. Such expansion represents the largest development to date of its library synthesis ... 02 December 2014 Drug Discovery collaboration with BioVersys AG extended Collaboration with BioVersys AG aiming at discovery of novel treatments against bacterial infections has been extended for the 4th consecutive year. 03 June 2013 Enamine Provides Exquiron with Large Novel Diverse Screening Compound Library Enamine and Exquiron are announcing a multi-year collaboration wherby Exquiron is acquiring a large screening compounds libraries from Enamine. 06 June 2012 Enamine creates the alliance to discover novel Rhomboid Protease inhibitors as potential drugs A collaboration agreement has been signed between Enamine, the Medical Research Council Laboratory of Molecular Biology (MRC LMB), Cambridge, UK, and the 31 January 2012 Enamine Provides Large Novel Diverse Compound Screening Library To Extend Relationship with BioFocus Enamine Ltd, a leading provider of screening compounds and chemical building blocks, today announced it has extended its long-standing relationship with BioFocus, with the acquisition by BioF... About us Our Research News & Events News Events Press Releases Collaboration Blog Contact us Events News Partners Posters Press Releases Blog Publications Press Kit Site Search Contact Us Follow us in social media: Cookies setting | Terms of use | Privacy policy Your choice regarding cookies on this site We use cookies to optimise site functionality and give you the best possible experience. AcceptManage Preferences